Contrast Media Market Research Report Information By Type (Iodinated Contrast Media, Gadolinium-Based Contrast Media), By Form (Tablet, Powder, Liquid, Paste), By Procedures (X-ray/Computed Tomography, Magnetic Resonance Imaging), By Application (Cardiovascular Disease, Oncology, Gastrointestinal Disorders), And By Region (North America, Europe, Asia-Pacific, And Rest Of The World) – Market Forecast Till 2030
The contrast media market size was valued at USD 3.1 billion in 2022 and is projected to grow from USD 3.2 Billion in 2023 to USD 4.2 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 4.01% during the forecast period (2023 – 2030). A growing number of diagnostics procedures and the increasing popularity of minimally invasive procedures are the key market drivers enhancing market growth.
The major factors for the growth of the contrast media market include the increase in the number of chronic diseases, rising demand for image-guided procedures and diagnostics, and a large number of approvals for contrast agents.
The healthcare system has witnessed huge challenges as a result of the COVID-19 pandemic. All outpatient treatments were restricted during the COVID-19 pandemic to reduce the risk of viral transmission. Conversely, a chest CT scan is a important procedure used in the diagnosis of COVID-19. Thus, the market for contrast media is estimated to increase in size during the forecast period.
Get Free Sample PDF Brochure @ https://www.marketresearchfuture.com/sample_request/1284
It Increase the prevalence of cancer and cardiac disease. Increasing patient pool increases the demand for medical imaging, which boosts the contrast media market.
Market Segmentation
The contrast media market segmented into type, form, procedures, application.
Based on the type, contrast market segmented into iodinated contract media, godalinium based contrast media and microbubble contrast media, Barium-based Contrast Media.
Based on the procedure, contrast market segmented into X-ray/Computed Tomography (CT), Ultrasound and Magnetic Resonance Imaging (MRI).
Based on the application, contrast market segmented into Cardiovascular Disease, Neurological Disorders and Gastrointestinal Disorders and Oncology.
Key Playersanies Profiled
Some of the top market players are:
- Bayer AG (GERMANY)
- Bracco Diagnostic Inc (US)
- Jodas Expoim (INDIA)
- Magnus Health (US)
Browse In-depth Market Research Report (90 Pages) on Contrast Media: https://www.marketresearchfuture.com/reports/contrast-media-market-1284
Regional Analysis
The major driving factor for the market’s growth in the United States is increasing in chronic diseases, such as cardiovascular and neurological diseases.
The largest consumer market for contrast media in North America is United States.
North America Expected to Continue Market Dominance over the Forecast Period till 2030.
North America holds a major share in the contrast media market and is expected to show a similar trend over the forecast period without significant change. The first gadolinium-based contrast type agent was approved in the United States. Four type agents were approved in the United States in the past decade, and this has resulted in a strong trend in the industry to continue to find more accurate, and safe agents. The contrast media sales are expected to grow in the United States over the happening years.
Discover More Research Reports on Healthcare Industry by Market Research Future:
Magnetic Resonance Imaging (MRI) Systems Market Research Report: Information By Type (Open MRI and Closed MRI), By Field Strength (High-Field MRI Systems), By Disease Application (Brain and Neurological MRI), and by End-Users (Hospitals & Clinics), and By Region (North America, Europe, Asia-Pacific, And Rest Of The World) – Market Forecast Till 2030
Spectral Computed Tomography Market: Information by Application (Oncology, Cardiology, Musculoskeletal Disorders and Gastrointestinal Diseases), End User (Diagnostic Centers and Hospitals & Clinics) and Region (Americas, Europe, Asia-Pacific and the Middle East & Africa) – Forecast till 2030
Gastrointestinal Drugs Market Research Report: Information by Drug Class (Acid Neutralizers, Anti-Inflammatory Drugs, Antidiarrheal and Laxatives, Antiemetic and Antinauseants, Biologics and others), Route of Administration (Oral, Parenteral and Rectal), Application (Inflammatory Ulcerative Colitis, Irritable Bowel Syndrome, Crohn’s Disease, Celiac Disease, Gastroenteritis and others), Distribution Channel (Retail Pharmacies, Online Pharmacies and Hospital Pharmacies) and Region (Americas, Europe, Asia-Pacific and the Middle East & Africa) – Forecast till 2030
About Market Research Future:
Market Research Future (MRFR) is a global market research company that takes pride in its services, offering a complete and accurate analysis with regard to diverse markets and consumers worldwide. Market Research Future has the distinguished objective of providing the optimal quality research and granular research to clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help answer your most important questions.
Contact:
Market Research Future (Part of Wantstats Research and Media Private Limited)
99 Hudson Street, 5Th Floor
New York, NY 10013
United States of America
+1 628 258 0071 (US)
+44 2035 002 764 (UK)
Email: sales@marketresearchfuture.com
Website: https://www.marketresearchfuture.com